Back to search

Article

<i>LRRK2</i> G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3

2024-03-03

Abstract excerpt

The Leucine-rich repeat kinase-2 ( LRRK2 ) G2019S mutation, resulting in aberrantly enhanced kinase activity, is one of the well-recognized genetic risk factors in Parkinson’s Disease (PD). Increased LRRK2 activity was also observed in immune cells from PD patients. Emerging results have also unveiled an upsurge in α-synuclein (α-syn)-specific CD4 + T cell responses in PD patients. Given that LRRK2 mutations in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23c0d5d2-a039-593e-920b-9f74c1a02ad9
DOI
10.1101/2024.02.28.582561
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>LRRK2</i> G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3DOI 10.1101/2024.02.28.582561
Select a neighboring publication to make it the new centre.